Showing results (131-140 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|August 10, 2018
Phase 1 Single- and Multiple-Ascending-Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG-348, a First-in-Class Allosteric Activator of Pyruvate Kinase R, in Healthy VolunteersHua Yang, Elizabeth Merica, Yue Chen, et al.
Clinical Pharmacology in Drug Development|April 26, 2018
Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy SubjectsOlivier J David, Rhett Behrje, Parasar Pal, et al.
Clinical Pharmacology in Drug Development|April 25, 2018
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Administration of Verinurad and Febuxostat in Healthy Male VolunteersJesse Hall, Michael Gillen, Xiaojuan Yang, et al.
Clinical Pharmacology in Drug Development|May 11, 2018
An Open-Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide PharmacokineticsYan Li, Xiaomin Wang, Liangang Liu, et al.
Clinical Pharmacology in Drug Development|May 12, 2018
Comparative Randomized, Single-Dose, Two-Way Crossover Open-Label Study to Determine the Bioequivalence of Two Formulations of Dalfampridine TabletsAbdel Qader Al Bawab, Bashar A Alkhalidi, Esra'a Albarahmieh, et al.
Clinical Pharmacology in Drug Development|June 8, 2018
Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male VolunteersFriederike Kanefendt, Uwe Thuß, Michael Becka, et al.
Clinical Pharmacology in Drug Development|June 28, 2018
Clinical Pharmacokinetics and Drug-Drug Interaction Potential for Coadministered SCY-078, an Oral Fungicidal Glucan Synthase Inhibitor, and TacrolimusStephen Wring, Gail Murphy, George Atiee, et al.
Clinical Pharmacology in Drug Development|May 26, 2017
Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHDRichard H Weisler, Jeffrey G Stark, Carolyn Sikes
Clinical Pharmacology in Drug Development|May 26, 2017
A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy AdultsAnn Childress, Jeffrey G Stark, Russ McMahen, et al.
Clinical Pharmacology in Drug Development|April 17, 2018
A Prospective Randomized, Double-Blind, Two-Period Crossover Pharmacokinetic Trial Comparing Green Coffee Bean Extract-A Botanically Sourced Caffeine-With a Synthetic USP ControlKayce Morton, Katelin Knight, Douglas Kalman, et al.
Pageof 135